Table 1. Common genetic variations in genes involved in LDL-cholesterol metabolism that have an effect on the risk of myocardial infarction.
Gene | Frequency of allele conferring elevated risk | Rise in LDL-cholesterol per copy of allele conferring elevated risk | Effect of allele on risk of myocardial infarction (odds ratio, OR) | p-value for association with myocardial infarction | Reference |
PCSK9 | 80% | + 15% | OR 1.13 | 0.004 | (21) |
Apo E | 18% | + 14% | OR 1.17 | 0.0001 | (21) |
LDLR | 11% | + 6% | OR 1.18 | 0.0001 | (19) |
Apo B | 33% | + 5% | OR 1.1 | 0.004 | (20) |
OR, odds ratio for one allele; PCSK9, proprotein convertase subtilisin/kexin type 9; Apo E, apolipoprotein E; LDLR, low-density lipoprotein receptor; Apo B, apolipoprotein B The differing values for statistical significance are due to large differences in sample size